Ginkgo Bioworks HoldingsDNABW 63 Days Payable is 395.79 as of Mar. 2026, which is 386% above its 10-year median of 81.46. GuruFocus rates DNABW with a GF Score™ of 63/100. The stock has 5 warning signs investors should review. Among 707 Biotechnology companies, Ginkgo Bioworks Holdings ranks better than 50.78% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DNABW vs CADL, CABA, CLYM: Days Payable Comparison
For the Biotechnology subindustry, Ginkgo Bioworks Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ginkgo Bioworks Holdings Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Ginkgo Bioworks Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Ginkgo Bioworks Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ginkgo Bioworks Holdings (DNABW) has a Days Payable of 395.79 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ginkgo Bioworks Holdings and its competitors. This is 386% above median its historical median of 81.46. Over the past decade, Ginkgo Bioworks Holdings' Days Payable has ranged from 16.66 to 324.83. According to the industry distribution chart, Ginkgo Bioworks Holdings ranks #348 out of 707 companies in the Biotechnology industry, placing it in the top 49.2%.
Is Ginkgo Bioworks Holdings' Days Payable too high?
Ginkgo Bioworks Holdings' current Days Payable of 395.79 is 386% above median its 10-year median of 81.46. Over the past 10 years, this metric has ranged from a low of 16.66 to a high of 324.83. The Biotechnology industry median Days Payable is 113.76. Ginkgo Bioworks Holdings' value of 395.79 is 247.9% above this industry median. Based on the distribution chart, Ginkgo Bioworks Holdings ranks #348 out of 707 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' Days Payable compare to CADL and CABA?
According to the Biotechnology industry distribution chart, Ginkgo Bioworks Holdings ranks #348 out of 707 companies for Days Payable. This puts Ginkgo Bioworks Holdings in the upper half of its industry. The industry median Days Payable is 113.76. Ginkgo Bioworks Holdings' value of 395.79 is 247.9% above this benchmark. Historically, Ginkgo Bioworks Holdings' own Days Payable has ranged from 16.66 to 324.83 over the past decade. While the company's 10-year median is 81.46 vs. the industry median of 113.76, Ginkgo Bioworks Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ginkgo Bioworks Holdings's current Days Payable of 395.79 is 247.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ginkgo Bioworks Holdings and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ginkgo Bioworks Holdings's current Days Payable is 395.79, which is 386% above median its own 10-year median of 81.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Ginkgo Bioworks Holdings (DNABW) has a current Days Payable of 395.79. The current Days Payable is 395.79, which is 386% above median its 10-year median of 81.46 and 247.9% above the Biotechnology industry median of 113.76. Ginkgo Bioworks Holdings' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (DNABW), the current Days Payable is 395.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
63GF Score
Get the complete analysis for DNABW
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DNABW has been successfully added to your 
